Q10677 (Q10677): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed an Item)
(‎Removed claims)
Property / EU contribution
189,000.0 Czech koruna
Amount189,000.0 Czech koruna
UnitCzech koruna
 
Property / EU contribution: 189,000.0 Czech koruna / rank
Normal rank
 
Property / EU contribution
7,560.0 Euro
Amount7,560.0 Euro
UnitEuro
 
Property / EU contribution: 7,560.0 Euro / rank
Preferred rank
 
Property / EU contribution: 7,560.0 Euro / qualifier
exchange rate to Euro: 0.04 Euro
Amount0.04 Euro
UnitEuro
 
Property / EU contribution: 7,560.0 Euro / qualifier
point in time: 1 October 2020
Timestamp+2020-10-01T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
 
Property / budget
252,000.0 Czech koruna
Amount252,000.0 Czech koruna
UnitCzech koruna
 
Property / budget: 252,000.0 Czech koruna / rank
Normal rank
 
Property / budget
10,080.0 Euro
Amount10,080.0 Euro
UnitEuro
 
Property / budget: 10,080.0 Euro / rank
Preferred rank
 
Property / budget: 10,080.0 Euro / qualifier
exchange rate to Euro: 0.04 Euro
Amount0.04 Euro
UnitEuro
 
Property / budget: 10,080.0 Euro / qualifier
point in time: 1 October 2020
Timestamp+2020-10-01T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
 

Revision as of 22:49, 11 February 2020

Project in Czech Republic financed by DG Regio
Language Label Description Also known as
English
No label defined
Project in Czech Republic financed by DG Regio

    Statements

    0 references
    75 percent
    0 references
    8 March 2017
    0 references
    31 December 2017
    0 references
    31 December 2017
    0 references
    VIDIA spol. s r.o.
    0 references
    0 references

    49°59'0.49"N, 14°30'9.11"E
    0 references
    25250
    0 references
    V rámci projektu bude proveden výběr a charakterizace antigenů pro diagnostiku neurodegenerativních onemocnění, jednak s ohledem na jejich komerční dostupnost, popř. možnou vlastní přípravu, na stav práv duševního vlastnictví a jednak s ohledem na jejich předpokládané využití pro diferenciální diagnostiku zamýšlených onemocnění. Vybrané antigeny budou dále ověřeny na panelech reálných vzorků se známou diagnózou. a. (Czech)
    0 references

    Identifiers

    CZ.01.1.02/0.0/0.0/16_045/0009746
    0 references